Richard Menziuso
Richard Menziuso was appointed in a total of 11 companies and resigned from 0 of these appointments.
Role
Director
Country Of Residence
United States
Nationality
American
Date of Birth
April 1975
Occupation
Controller
Active
3
Resigned
0
Dissolved
8
Other
0
Total
11
Companies
| Company | Timeline | Status | |
| Centessa Pharmaceuticals (UK) Limited Director • Controller | 10 Nov 2022←2 Years 10 Months→Current | Active | |
| Centessa Pharmaceuticals (Orexia) Limited Director • Controller | 1 Nov 2022←2 Years 1 Month→17 Dec 2024 | Dissolved | |
| Inexia Limited Director • Controller | 1 Nov 2022←1 Year 1 Month→26 Dec 2023 | Dissolved | |
| Lockbody Therapeutics Ltd Director • Controller | 1 Nov 2022←2 Years 1 Month→17 Dec 2024 | Dissolved | |
| Ultrahuman Four Limited Director • Controller | 1 Nov 2022←1 Year 1 Month→26 Dec 2023 | Dissolved | |
| Ultrahuman Two Limited Director • Controller | 1 Nov 2022←1 Year 1 Month→26 Dec 2023 | Dissolved | |
| Centessa Pharmaceuticals (Morphogen-Ix) Limited Director • Controller | 1 Nov 2022←2 Years 1 Month→17 Dec 2024 | Dissolved | |
| Capella Bioscience Ltd Director • Controller | 1 Nov 2022←2 Years 1 Month→17 Dec 2024 | Dissolved | |
| Z Factor Limited Director • Controller | 1 Nov 2022←2 Years 10 Months→Current | Active | |
| Apcintex Limited Director • Controller | 1 Nov 2022←2 Years 10 Months→Current | Active | |
Mutual People
- Oakwood Corporate Secretary LimitedLockbody Therapeutics Ltd, Capella Bioscience Ltd, Centessa Pharmaceuticals (Morphogen-Ix) Limited, and 8 more are mutual companies.
- Marella ThorellInexia Limited, Centessa Pharmaceuticals (Orexia) Limited, Ultrahuman Four Limited, and 8 more are mutual companies.
- The Cambridge Partnership LimitedLockbody Therapeutics Ltd, Ultrahuman Four Limited, Z Factor Limited, and 4 more are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
